Transition to raloxifene with and without low-dose estrogen therapy in postmenopausal women: effects on serum lipids and fibrinogen - a pilot study

By O'Neill S. M.   Eden J.   Baber R.   Ekangaki A.   Stocks J. M.   Wolthers T.   Davis S. R.  

Climacteric, Vol. 6, Iss. 4, 2003-12 ,pp. : 347-353

Informa Healthcare

Access to resources Recommend Favorite

The differential effect of estrogen, estrogen-progestin and tibolone on coagulation inhibitors in postmenopausal women

By Keramaris N. C.   Christodoulakos G. E.   Lambrinoudaki I. V.   Dalamanga A.   Alexandrou A. P.   Bramis J.   Bastounis E.   Creatsas G. C.  

Climacteric, Vol. 10, Iss. 5, 2007-10 ,pp. : 400-407

Informa Healthcare

Access to resources Recommend Favorite

Low-dose intravaginal estradiol delivery using a Silastic vaginal ring for estrogen replacement therapy in postmenopausal women: a review

By Sarkar N. N.  

The European Journal of Contraception and Reproductive Health Care, Vol. 8, Iss. 4, 2003-12 ,pp. : 217-224

Informa Healthcare

Access to resources Recommend Favorite

Low- and standard-estrogen dosage in oral therapy: dose-dependent effects on insulin and lipid metabolism in healthy postmenopausal women

By Villa P.   Sagnella F.   Perri C.   Suriano R.   Costantini B.   Macri F.   Ricciardi L.   Lanzone A.  

Climacteric, Vol. 11, Iss. 6, 2008-01 ,pp. : 498-508

Informa Healthcare

Access to resources Recommend Favorite

Estrogen and postmenopausal estrogen/progestin therapy: effect on endothelium-dependent prostacyclin, nitric oxide and endothelin-1 production

By Mikkola T.   Viinikka L.   Ylikorkala O.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 79, Iss. 1, 1998-07 ,pp. : 75-82

Elsevier

Access to resources Recommend Favorite